Archive
Minutes of the General Meeting 2025 Ambusol AB (publ) has held an Extraordinary General Meeting where shareholders resolved to authorize the Board of Directors to issue new shares to strengthen the company’s capital base ahead of upcoming clinical studies. All resolutions were passed in accordance with the Board’s proposals.
Planning Phase Between June 11 and June 19, 2025, the company visited four hospitals in China as part of its ongoing clinical outreach and partnership development efforts. Planning Phase: Multi-center clinical trials in China (40 GBM patients across 4 hospitals).